drug
triptorelin pamoate ER
Marketedupdated 3mo agoby Azurity Pharmaceuticals Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 3indications
investigational
Prostate Cancer
all catalysts(64)
approval · 64
Jun 15, 2000
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Oct 23, 2000
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Jun 20, 2001
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Jun 29, 2001
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Jan 15, 2002
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Jan 15, 2002
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Oct 20, 2005
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Oct 20, 2005
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Feb 16, 2007
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Feb 16, 2007
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Apr 14, 2008
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Apr 14, 2008
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Mar 10, 2010
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Mar 16, 2010
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Mar 17, 2010
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Jan 14, 2011
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Jan 14, 2011
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Jan 14, 2011
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
May 19, 2011
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
May 19, 2011
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
May 19, 2011
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Mar 12, 2013
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Mar 12, 2013
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Mar 12, 2013
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Apr 11, 2013
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Apr 11, 2013
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Apr 19, 2013
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Apr 25, 2013
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Apr 25, 2013
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Apr 25, 2013
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Jun 19, 2013
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Mar 14, 2014
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Jul 3, 2014
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Jul 11, 2014
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Jul 11, 2014
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Jul 11, 2014
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Jul 15, 2014
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Jul 15, 2014
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Jan 20, 2015
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Jan 26, 2015
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Feb 3, 2015
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Jun 29, 2017
approval
TRIPTODUR KIT (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Dec 14, 2018
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Dec 14, 2018
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Dec 14, 2018
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Oct 4, 2019
approval
TRIPTODUR KIT (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Apr 22, 2022
approval
TRIPTODUR KIT (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Dec 7, 2022
approval
TRIPTODUR KIT (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Mar 3, 2023
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Mar 3, 2023
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Mar 3, 2023
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Nov 17, 2023
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Nov 17, 2023
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Nov 17, 2023
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Apr 12, 2024
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Apr 12, 2024
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Apr 12, 2024
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Mar 11, 2025
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Mar 11, 2025
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Mar 11, 2025
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Sep 23, 2025
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Sep 23, 2025
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Sep 23, 2025
approval
TRIPTODUR KIT (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Sep 23, 2025
approval
TRELSTAR (TRIPTORELIN PAMOATE) — FDA approval
triptorelin pamoate ER
→
Trials studying triptorelin pamoate ER
- phase3Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate
- phase2Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients
- phase3A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Participants With Central Precocious Puberty.
- phase3Efficacy and Safety Study of Triptorelin 3-Month Formulation in Chinese Children With Central Precocious Puberty.
- phase2Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jun 30, 2029
~2.9 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- Jun 30, 2029formulationUS 101661812.9y
- Jun 30, 2029formulationUS 101661812.9y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 16m ago
Found something off?
comments(0)
5-min edit window · permanent after that